Drugs and uses

China Patent

APP PUB NO CN-103211821-A
SERIAL NO

201310054309

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to methods to treat specified clinical disorders such as hyperglycemia, type 2 diabetes, arthritis and multiple sclerosis. The invention also provides methods to identify and characterize drugs, which are characterized in part by eliciting a variable biologic or therapeutic effect on a biomolecule at one time and relative normalization of the biomolecule at another time point. Compounds include 17alpha-ethynylandrost-5-ene-3beta,7beta, 17beta-triol or androst-5-ene-3beta,4beta, 16alpha, 17beta-tetrol, which can be used as reference standards to facilitate assessing and characterizing such candidate drugs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HOLLIS EDEN PHARMACEUTICALSNot Provided

International Classification(s)

Inventor(s)

Inventor Name Address
FRINCKE JAMES M 339 SHOEMAKER LANE SOLANA BEACH CALIFORNIA 92705 UNITED STATES OF AMERICA
READING CHRISTOPHER L -

Cited Art Landscape

Load Citation